Physician profile
Tyler Patton
NPI 1750910816
$1,603.41
in general payments reported to CMS, 2019-2025
14 companies · $667 in 2025
The $667 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.02 · 2023: $220 · 2024: $634 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $496.42 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $408.43 | 2023-2025 | |
| Novo Nordisk INC | $234.32 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $156.01 | 2022-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $57.12 | 2022-2024 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $54.02 | 2024-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $44.48 | 2023-2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.59 | 2025 | Caplyta |
| Exact Sciences Corporation | $29.91 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $24.65 | 2024 | |
| Viatris Specialty LLC | $17.66 | 2025 | Yupelri |
| Pfizer INC. | $16.50 | 2024 | |
| Amgen INC. | $15.36 | 2024 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.94 | 2024 | Xifaxan, Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.